Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 1999, p. 1591-1594, Vol. 37, No. 5
Institut de
Microbiologie1 and Division Autonome de
Médecine Préventive
Hospitalière,2 Centre Hospitalier
Universitaire Vaudois, 1011 Lausanne, Switzerland
Received 8 September 1998/Returned for modification 2 November
1998/Accepted 7 February 1999
The MRSA-Screen test (Denka Seiken Co., Ltd., Tokyo, Japan),
consisting of a slide latex agglutination kit that detects PBP 2a with
a monoclonal antibody, was blindly compared to the oxacillin disk
diffusion test, the oxacillin-salt agar screen, and PCR of the
mecA gene for the detection of methicillin resistance in
Staphylococcus aureus. A total of 120 methicillin-susceptible S. aureus (MSSA) and 80 methicillin-resistant S. aureus (MRSA) isolates, defined by
the absence or presence of the mecA gene, respectively,
were tested. The MRSA-Screen test, the oxacillin disk diffusion test, and the oxacillin-salt agar screening test showed sensitivities of 100, 61.3, and 82.5% and specificities of 99.2, 96.7, and 98.3%, respectively. We conclude that the MRSA-Screen is a very accurate, reliable, and fast test (15 min) for differentiation of MRSA from MSSA
colonies on agar plates.
Resistance to methicillin (and to
all Bacterial isolates.
A total of 200 S. aureus
clinical isolates collected between 1987 and 1998 from our hospital and
15 neighboring hospitals were used in this study. All isolates were
identified by conventional tests. Isolates from the neighboring
hospitals (n = 33) were sent to our laboratory because
of the difficulty of assessing susceptibility to oxacillin by
phenotypic methods. The definitions of methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) were based on the presence or absence,
respectively, of the mecA gene by PCR. Among 120 MSSA
isolates (19 penicillin susceptible and 101 penicillin resistant), 40 were susceptible to all non-
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Evaluation of MRSA-Screen, a Simple Anti-PBP 2a
Slide Latex Agglutination Kit, for Rapid Detection of Methicillin
Resistance in Staphylococcus aureus
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
-lactam antibiotics) in Staphylococcus aureus is
primarily associated with the acquisition of the mecA gene
coding for the penicillin-binding protein 2a (PBP 2a), involved in
bacterial cell wall synthesis (1, 13, 31). The detection of
methicillin resistance, however, is complicated by the fact that its
phenotypic expression in many strains is heterogeneous (9,
14). This has resulted in the development of various laboratory
techniques to enhance the expression of this resistance in vitro
(2, 6, 17). mecA gene detection tests based on
PCR or DNA hybridization performed only by specialized laboratories has
proved to be more specific and sensitive than conventional tests,
particularly in very heterogeneous strains (16, 22). So far,
no simple and rapid method aimed at the direct detection of PBP 2a has
been commercialized (11). The purpose of the present study
is to test such a candidate.
-lactam antibiotics tested, 51 showed
resistance to one, and 29 showed resistance to more than one
non-
-lactam antibiotic. Eighty MRSA isolates were carefully selected
on the basis of molecular typing (60 different pulsed-field gel
electrophoresis [PFGE] patterns) and on the basis of various levels
of heterogeneous resistance to oxacillin (35 heterogeneously and 45 homogeneously resistant isolates).
80°C),
streaked onto Columbia blood agar plates, and incubated under aerobic
conditions at 35°C for 24 h. An isolated colony was
picked from each plate, streaked onto two new Columbia blood agar
plates, and incubated for 24 h. All inocula were prepared from
these subcultures. All isolates were blindly tested. Two control
strains, one MRSA (ATCC 33591) and one MSSA (ATCC 29213) strain, were
included in each batch.
MRSA-Screen test. The MRSA-Screen test (Denka Seiken Co., Ltd., Tokyo, Japan) was performed according to the manufacturer's instructions by batches of 20 isolates, including the control strains. The sample preparation was made as follows. Ten to 20 S. aureus colonies from a fresh blood agar plate were suspended in a 1.5-ml microtube containing 4 drops (200 µl) of extraction reagent no. 1 (0.1 M NaOH). The suspension was boiled for 3 min, and then 1 drop (50 µl) of extraction reagent no. 2 (0.5 M KH2PO4) was added and mixed well. After a centrifugation step (at 1,500 × g for 5 min at room temperature), 50 µl of the supernatant was placed on the slide for testing and mixed with 1 drop (25 µl) of anti-PBP 2a monoclonal antibody-sensitized latex. For the negative control, 50 µl of the supernatant was placed on the slide for testing and mixed with 1 drop (25 µl) of negative-control latex. Mixing for 3 min was performed with a shaker. When agglutination occurred within 3 min, it was visually quantified as a score between 1+ and 3+. All the isolates were tested twice, and the results were interpreted blindly by two different persons.
Phenotypic methods. The oxacillin disk diffusion test and oxacillin-salt agar screening test were carried out on all the isolates according to the recommendations of the National Committee for Clinical Laboratory Standards (NCCLS) (23-25). Both tests were read after 24 h of incubation. Susceptibility to 11 other antibiotics (penicillin, cephalothin, ceftriaxone, gentamicin, ciprofloxacin, clindamycin, fusidic acid, erythromycin, trimethoprim-sulfamethoxazole, rifampin, and vancomycin) was also tested by the disk diffusion method according to NCCLS recommendations.
mecA gene. Detection of the mecA gene was performed blindly for all isolates by using the method described by Tokue et al. with some modifications (28). The extraction technique was simplified by directly suspending 2 to 5 colonies in 200 µl of water; the suspension was diluted 1:10 and 1:100 in water, and the DNA was released by boiling the suspensions for 5 min at 95°C. One positive MRSA control strain (ATCC 33591), one negative MSSA control strain (ATCC 25923), and water as an extraction control were included in each run.
Molecular typing. Molecular typing was performed by PFGE on all MRSA isolates (4).
Repeat testing. When S. aureus isolates yielded discrepant results among the MRSA-Screen test, oxacillin-salt agar screening test, and mecA gene detection, the tests were repeated blindly twice from the same Columbia blood agar plate.
-Lactamase testing.
Chromogenic nitrocefin disks
(Cefinase; BBL Becton Dickinson, Cockeysville, Md.) were used
according to the manufacturer's instructions to test MSSA isolates
that appeared resistant to oxacillin by phenotypic methods.
E-tests. Oxacillin MICs were measured for all isolates showing discordant results between phenotypic methods and the MRSA-Screen. E-tests (AB Biodisk, Solna, Sweden) were performed according to the manufacturer's advice on Mueller-Hinton agar supplemented with 2% NaCl and read after 24 h of incubation. In addition, penicillin, amoxicillin, and amoxicillin-clavulanate MICs were measured for the four MSSA isolates that appeared resistant to oxacillin by phenotypic methods.
Results.
Table 1 summarizes the
results obtained with the MRSA-Screen test, oxacillin disk diffusion
method, and oxacillin-salt agar screening test. Table
2 lists the isolates with discrepant
results. The positive and negative control strains, included blindly in each of 11 batches of MRSA-screen tests, gave the expected results. No
agglutination occurred when the 200 S. aureus isolates were tested with the negative-control latex. The MRSA-Screen test by slide latex agglutination showed complete concordance with the detection by PCR of the mecA gene, except for one
false-positive result among the 120 mecA gene-negative
S. aureus isolates tested. This false-positive agglutination
was graded 1+ and gave no agglutination upon retesting. Results of
duplicate testing were in agreement for the remaining 199 isolates,
which proves the good reproducibility of the test (99.5%).
Quantification of the agglutination test reaction (1+ to 3+) for the 80 MRSA isolates did not correlate with their level of heterogeneous
resistance to methicillin. Among the 35 heterogeneously resistant MRSA
isolates, 31 showed a 3+ agglutination test reaction and 4 showed a 2+
reaction. Of the remaining 45 isolates homogeneously resistant to
methicillin, one showed a 1+, 6 showed a 2+, and 38 showed a 3+
agglutination test reaction. Upon retesting, the grading of the
agglutination reaction was identical for 69 of 80 MRSA isolates; of the
remaining 11 isolates (4 heterogeneously resistant and 7 homogeneously resistant), the grading changed from 3+ to 2+ or
from 2+ to 3+ for 10 and from 1+ to 2+ for the last isolate.
|
|
-lactamase, associated with a
reduction in the MIC from 24 to 1 µg/ml when clavulanate was added to
amoxicillin, was demonstrated in only one isolate. Overproduction of
-lactamase in this isolate may contribute to the oxacillin
resistance observed with the oxacillin disk diffusion test
(21). The three remaining strains were not
-lactamase
producers and could thus be classified as MOD-SA (modified S. aureus) isolates (15, 29).
Discussion. The MRSA-Screen test detected all the 80 MRSA isolates and misclassified as MRSA only 1 of 120 MSSA isolates. Compared to the standard agar disk diffusion test and to the oxacillin-salt agar screening test, the MRSA-Screen test showed higher sensitivity and specificity. Fourteen heterogeneously resistant isolates, while they were mecA gene positive by PCR, did not express any resistance to oxacillin by the conventional phenotypic methods. However, these mecA gene-positive isolates were categorized as MRSA by the MRSA-Screen test, which detects PBP 2a, confirming that expression of the resistance is under the control of other determinants, such as the BlaI, mecR1-mecI, and fem genes, whose mechanisms and interactions are still not fully understood (3, 8, 12, 18).
Technically the test was easy to perform, requiring only microtubes, boiling water, a table centrifuge, and a manual pipetter. The test gave results in 15 min, making it the fastest test to our knowledge to reliably detect oxacillin resistance in S. aureus isolates. Even if most MRSA isolates agglutinated after 30 s of mixing time, some needed almost the 3 min recommended by the manufacturer to produce visible agglutination. The correct inoculum is also important, as at the beginning of the study we experienced two false-positive agglutination reactions when the inoculum used was about 10 times heavier than that recommended. The influences of various solid growth media on the sensitivity and specificity of the MRSA-Screen test were not investigated in the present study. As already reported, the oxacillin disk diffusion test was the least reliable test for detection of resistance to oxacillin in S. aureus (5, 20, 30). Of the 80 MRSA isolates, 20 had inhibitory-zone diameters in the susceptible range (
13 mm), 11 in the
intermediate range (11 to 12 mm), and 49 in the resistant range (
10
mm). As recommended by the NCCLS, we looked for associated resistance
and cross-resistance to other antibiotics as clues to suspect
methicillin resistance. Of the 11 antibiotics tested in addition to
oxacillin, ceftriaxone gave the best indication for oxacillin
resistance when both intermediate and resistant zone diameters were
considered as clues for oxacillin resistance. Among 120 MSSA isolates,
the ceftriaxone inhibitory-zone diameters would have suggested
resistance to oxacillin in only 4 cases. Of these four, two were
also falsely resistant to oxacillin by the oxacillin disk
diffusion test. Among 80 MRSA isolates, only 4 were ceftriaxone
susceptible, 3 of which were also susceptible to oxacillin by
disk diffusion. Although associated resistance to non-
-lactam
antibiotics is often found among MRSA isolates, there were 13 MRSA
isolates without any associated resistance in this study.
The oxacillin-salt agar screening test is recognized as a sensitive and
specific test (7, 10, 27). In our study the sensitivity was
low (82.5%). This is due to a bias of selection of the MRSA isolates,
as we included strains that were difficult to detect as being resistant
to methicillin by the oxacillin-salt agar screening test and oxacillin
disk diffusion. However, 13 of the 14 MRSA isolates not detected by the
oxacillin-salt agar screen test after 24 h of incubation showed
clear growth after reincubation for an additional 24 h. Therefore,
in order to further increase the sensitivity of the test, we
suggest looking for growth after 24 and 48 h of incubation.
In our study, reading all the oxacillin-salt agar screening plates
after 48 h of incubation would not have decreased the specificity
of the test compared to reading after 24 h of incubation.
Many methods have been evaluated for more accurate detection of
methicillin resistance in S. aureus (10, 19, 26).
The cost and workload of DNA probes or PCR to detect the
mecA gene have prevented their broad use in a clinical
microbiology laboratory. Therefore, detection of PBP 2a with this
simple agglutination kit offers an interesting new approach to
the rapid characterization of S. aureus as MRSA or MSSA.
The test has the major advantage over the phenotypic methods of
not being influenced by the various levels of expression of the
resistance, a parameter which in highly heterogeneously resistant
isolates tends to render classical and automated methods less accurate
(11). When applied to overnight primary culture agar media,
the MRSA-Screen test will shorten the delay for the detection of MRSA
to 1 day, versus 2 or 3 days for conventional methods, a potentially
significant improvement for both directed antibiotherapy and
epidemiological measures.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported in part by Pharma Consulting, Burgdorf, Switzerland.
We thank Marica Galazzo, Patricia Rudaz, and Dorothée Raffalli for their valuable technical help in this study.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland. Phone: 0041 21 314 40 57. Fax: 0041 21 314 40 60. E-mail: jacques.bille{at}chuv.hospvd.ch.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Archer, G. L., and E. Pennell.
1990.
Detection of methicillin resistance in staphylococci by using a DNA probe.
Antimicrob. Agents Chemother.
34:1720-1724 |
| 2. | Baker, C. N., M. B. Huang, and F. C. Tenover. 1994. Optimizing testing of methicillin-resistant Staphylococcus species. Diagn. Microbiol. Infect. Dis. 19:167-170[Medline]. |
| 3. | Berger-Bächi, B. 1996. Update on methicillin resistance mechanisms in staphylococci. Chemotherapy 42(Suppl. 2):19-26. |
| 4. | Brosch, R., C. Buchrieser, and J. Rocourt. 1991. Subtyping of Listeria monocytogenes serovar 4b by use of low-frequency-cleavage restriction endonucleases and pulsed-field gel electrophoresis. Res. Microbiol. 142:667-675[Medline]. |
| 5. | Chambers, H. F. 1993. Detection of methicillin resistant staphylococci. Infect. Dis. Clin. N. Am. 7:425-433[Medline]. |
| 6. |
Chambers, H. F., and C. J. Hackbarth.
1987.
Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus.
Antimicrob. Agents Chemother.
31:1982-1988 |
| 7. | Chambers, H. F. 1997. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 10:781-791[Abstract]. |
| 8. |
de Lencastre, H., and A. Tomasz.
1994.
Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus.
Antimicrob. Agents Chemother.
38:2590-2598 |
| 9. |
de Lencastre, H.,
A. M. Sá Figueiredo,
C. Urban,
J. Rahal, and A. Tomasz.
1991.
Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus.
Antimicrob. Agents Chemother.
35:632-639 |
| 10. | Dillard, S. C., K. B. Waites, E. S. Brookings, and S. A. Moser. 1996. Detection of oxacillin-resistance in Staphylococcus aureus by MicroScan MIC panels in comparison to four other methods. Diagn. Microbiol. Infect. Dis. 24:93-100[Medline]. |
| 11. |
Gerberding, J. L.,
C. Miick,
H. H. Liu, and H. F. Chambers.
1991.
Comparison of conventional susceptibility tests with direct detection of penicillin-binding protein 2a in borderline oxacillin-resistant strains of Staphylococcus aureus.
Antimicrob. Agents Chemother.
35:2574-2579 |
| 12. |
Hackbarth, C. J., and H. F. Chambers.
1993.
blaI and blaR1 regulate -lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
37:1144-1149 |
| 13. |
Hartman, B. J., and A. Tomasz.
1984.
Low-affinity penicillin-binding protein associated with -lactam resistance in Staphylococcus aureus.
J. Bacteriol.
158:513-516 |
| 14. |
Hartman, B. J., and A. Tomasz.
1986.
Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus.
Antimicrob. Agents Chemother.
29:85-92 |
| 15. |
Henze, U. U., and B. Berger-Bächi.
1996.
Penicillin-binding protein 4 overproduction increases -lactam resistance in Staphylococcus aureus.
Antimicrob. Agents Chemother.
40:2121-2125[Abstract].
|
| 16. | Hiramatsu, K., H. Kihara, and T. Yokota. 1992. Analysis of borderline-resistant strains of methicillin-resistant Staphylococcus aureus using polymerase chain reaction. Microbiol. Immunol. 36:445-453[Medline]. |
| 17. |
Huang, M. B.,
T. E. Gay,
C. N. Baker,
S. N. Banerjee, and F. C. Tenover.
1993.
Two percent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods.
J. Clin. Microbiol.
31:2683-2688 |
| 18. |
Hürlimann-Dalel, R. L.,
C. Ryffel,
F. H. Kayser, and B. Berger-Bächi.
1992.
Survey of the methicillin resistance-associated genes mecA, mecR1-mecI, and femA-femB in clinical isolates of methicillin-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
36:2617-2621 |
| 19. |
Knapp, C. C.,
M. D. Ludwig, and J. A. Washington.
1994.
Evaluation of BBL Crystal MRSA ID system.
J. Clin. Microbiol.
32:2588-2589 |
| 20. | Knapp, C. C., M. D. Ludwig, J. A. Washington, and H. F. Chambers. 1996. Evaluation of the Vitek GPS-SA card for testing of oxacillin against borderline-susceptible staphylococci that lack mec. J. Clin. Microbiol. 34:1603-1605[Abstract]. |
| 21. |
McDougal, L. K., and C. Thornsberry.
1986.
The role of -lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporin.
J. Clin. Microbiol.
23:832-839 |
| 22. |
Murakami, K.,
W. Minamide,
K. Wada,
E. Nakamura,
H. Teraoka, and S. Watanabe.
1991.
Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction.
J. Clin. Microbiol.
29:2240-2244 |
| 23. | National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th ed., vol. 17, no. 1. Approved standard M2-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 24. | National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed., vol. 17, no. 2. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 25. | National Committee for Clinical Laboratory Standards. 1998. Performance standards for antimicrobial susceptibility testing, vol. 18, no. 1. Eighth informational supplement. M100-S8. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 26. |
Petersson, A.,
H. Miorner, and C. Kamme.
1996.
Identification of mecA-related oxacillin resistance in staphylococci by the E test and the broth microdilution method.
J. Antimicrob. Chemother.
37:445-456 |
| 27. |
Skulnick, M.,
A. E. Simor,
D. Gregson,
M. Patel,
G. W. Small,
B. Kreiswirth,
D. Hathoway, and D. E. Low.
1992.
Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus.
J. Clin. Microbiol.
30:1985-1988 |
| 28. |
Tokue, Y.,
S. Shoji,
K. Satoh,
A. Watanabe, and M. Motomiya.
1992.
Comparison of a polymerase chain reaction assay and a conventional microbiologic method for detection of methicillin-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
36:6-9 |
| 29. |
Tomasz, A.,
H. B. Drugeon,
H. M. de Lencastre,
D. Jabes,
L. McDougall, and J. Bille.
1989.
New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity.
Antimicrob. Agents Chemother.
33:1869-1874 |
| 30. |
Ünal, S.,
K. Werner,
P. DeGirolami,
F. Barsanti, and G. Eliopoulos.
1994.
Comparison of tests for detection of methicillin-resistant Staphylococcus aureus in a clinical microbiology laboratory.
Antimicrob. Agents Chemother.
38:345-347 |
| 31. |
Utsui, Y., and T. Yokota.
1985.
Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
28:397-403 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»